Skip to main content

Table 2 Median percent of follow-up time with symptoms per infant

From: Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

Symptom [Median (SD)] Control n = 32 Biweekly n = 35 Weekly n = 35 Daily
n = 35
p-value p-for trend
Diarrhea 0 (2.2) 0 (2.2) 0 (0.5) 0 (1.5) 0.7 0.9
Watery or soft stool 0 (3.8) 0 (7.3) 1.1 (5.5) 1.0 (5.6) 0.3 0.3
Vomiting 0 (3.2) 0 (4.8) 0 (2.9) 0 (2.8) 0.4 0.8
Poor feeding 0 (4.1) 3.3 (8.4) 1.1 (6.6) 2.1 (4.0) 0.8 0.5
Colic 0 (9.0) 0 (6.7) 1.1 (3.0) 1.1 (3.9) 0.5 0.4
Cough 10.0 (17.1) 12.3 (17.1) 14.2 (14.8) 12.8 (12.7) 0.5 0.7
Congestion 9.1 (18.2) 14.8 (17.2) 13.6 (13.0) 15.7 (11.1) 0.4 1.0
Difficulty breathing 0 (4.1) 0 (5.6) 0 (4.5) 0 (1.2) 0.2 0.3
  1. Kruskal-Wallis Test, Test for Linear Trend
  2. Significance for p-values was set at 0.05